Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy
L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy.
L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - europepmc.org
Background The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy.
L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - search.ebscohost.com
Background: The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy
L Almouzain, F Stevenson, D Chard… - Multiple sclerosis …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
[HTML][HTML] Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy
L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - ncbi.nlm.nih.gov
Background The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy
L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - discovery.ucl.ac.uk
Background: The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy.
L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - search.ebscohost.com
Background: The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy.
L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - europepmc.org
Background The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …